Milestone Pharmaceuticals Inc

Research Milestone Pharmaceuticals Inc (MIST) on Bullrun: market cap USD 165.58M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMIST
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 165.58M
• Financial periodFY2025
• Net income-USD 63.06K
• Free cash flow-USD 49.34M

Valuation Snapshot

latest market cap is USD 165.58M.

About Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR).

Frequently asked questions

What is Milestone Pharmaceuticals Inc's market cap?

Milestone Pharmaceuticals Inc's market capitalization is USD 165.58M.

What does Milestone Pharmaceuticals Inc do?

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.